Llwytho...
Establishment of anti-mesothelioma monoclonal antibodies
BACKGROUND: Mesotheliomas are aggressive, therapy-resistant tumors that are predicted to increase in incidence at least until 2020. The prognosis of patients with mesothelioma is generally poor because they are typically diagnosed at a late stage and their tumors are resistant to current conventiona...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | BMC Res Notes |
|---|---|
| Prif Awduron: | , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BioMed Central
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4921032/ https://ncbi.nlm.nih.gov/pubmed/27342200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-016-2128-x |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|